Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies
Clinical trial NCT02626065 · COMPLETED
Trial details
- NCT number
- NCT02626065
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-23
- Primary completion
- 2017-12-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.